http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112694507-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-00 |
| filingDate | 2020-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112694507-B |
| titleOfInvention | Tetrahydro anthraquinone glycoside compound and application thereof in preparation of antitumor drugs |
| abstract | The invention provides a novel tetrahydroanthraquinone glycoside compound and application thereof in preparation of antitumor drugs, the novel tetrahydroanthraquinone glycoside compound has a good inhibition effect on growth and proliferation of lung cancer, breast cancer, colon cancer and liver cancer cells, can induce tumor cells to generate morphological change, promotes expression of tumor cell apoptosis-related protein to induce tumor cells to generate apoptosis, shows excellent antitumor characteristics, and provides a new selection and approach for research and development of antitumor drugs. |
| priorityDate | 2020-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.